BioSpace recaps 2024’s top venture capital rounds in biopharma, from Xaira Therapeutics’ blockbuster $1B raise to ...

Heading into fiscal 2025, CEO David Ricks said the company expects sales of weight-loss drugs will continue growing, and noted that it expects "to produce at least 60% more salable doses" of the drugs ...

Terence Flynn, Biotech Analyst at Morgan Stanley, discusses Eli Lilly's recent stock boost and its designation as Morgan Stanley's top pick for 2025. He highlights the robust growth potential of Eli ...

When, like Lilly Palmer as DJ has both the command of the room and the capacity to build an attractive set there's only one way this can go and that's bigger at 150 BPM.

The activation marked the latest phase of the ongoing It Takes 2 campaign from Boehringer Ingelheim and Eli Lilly.

Former VIP lounge host and Southern Hospitality cast member Grace Lilly is ready to embrace the next chapter in her life.

The drugmaker launched a campaign supporting its weight loss medication Contrave, all backed by a cover version of Lesley Gore’s 1963 hit “You Don’t Own Me.” ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been ...

Stocks like Rail Vikas Nigam, CESC, Dhanlaxmi Bank, Jubilant Ingrevia, Adani Green Energy, Archean Chemical Industries, Century Enka, Bank of India, Prataap Snacks, Power Grid Corporation of India, ...

It’s nearly impossible to keep up with the avalanche of new songs that arrive every year. We’re here to help: Find a gem you may have missed from the 450-plus tracks Jon Pareles and Lindsay ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...

Eli Lilly (LLY) closed at $795.67 in the latest trading session, marking a -0.08% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 1.1%. Elsewhere ...